Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
524414 NORRIS

Norris Medicines Share Price

 

 

Norris Medicines live price: ₹14. It opened at ₹14 vs previous close ₹14; intraday high/low: ₹14/₹14. The 50 & 200 DMA stand at ₹14.23/₹15.24.

Norris Medicines Performance

  • Today's Low
  • ₹14
  • Today's High
  • ₹14
  • 52 Week Low
  • ₹12
  • 52 Week High
  • ₹22
  • Open Price₹14
  • Previous Close₹14
  • Volume55
  • 50 DMA₹14.23
  • 100 DMA₹14.50
  • 200 DMA₹15.24

Norris Medicines Chart

Investment Returns

  • Over 1 Month -5.08%
  • Over 3 Month -2.51%
  • Over 6 Month -14.79%
  • Over 1 Year -18.32%

Smart Investing Starts Here Start SIP with Norris Medicines for Steady Growth!

Invest Now

Norris Medicines Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -25
  • PEG Ratio
  • -0.8
  • Market Cap Cr
  • 14
  • P/B Ratio
  • -0.9
  • Average True Range
  • 1.03
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.09
  • RSI
  • 47.87
  • MFI
  • 45.82

Norris Medicines Financials

Norris Medicines Technicals

EMA & SMA

Current Price
₹14.00
0 (0%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹14.28
  • 50 Day
  • ₹14.23
  • 100 Day
  • ₹14.50
  • 200 Day
  • ₹15.24

Resistance and Support

13.83 Pivot Speed
  • R3 14.67
  • R2 14.33
  • R1 14.17
  • S1 13.67
  • S2 13.33
  • S3 13.17

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Norris Medicines has an operating revenue of Rs. 9.44 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of -20% needs improvement, NULL From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 36 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Norris Medicines Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-14 Quarterly Results
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
2025-05-28 Audited Results
2025-02-13 Quarterly Results & Others Inter-alia, to consider 1. Requests from Mr. Nimish Bhishma Thakore, for reclassification from Promoter / Promoter Group into Public Category. 2. Other business matters.

Norris Medicines Shareholding Pattern

34.01%
0.01%
0.06%
20.77%
45.15%

Norris Medicines FAQs

Norris Medicines share price is ₹14 As on 15 May, 2026 | 03:52

The Market Cap of Norris Medicines is ₹14 Cr As on 15 May, 2026 | 03:52

The P/E ratio of Norris Medicines is -25 As on 15 May, 2026 | 03:52

The PB ratio of Norris Medicines is -0.9 As on 15 May, 2026 | 03:52

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23